The South African Health Products Regulatory Authority says there are no major safety concerns with the Johnson and Johnson vaccine.
It has studied the data from the Sisonke trial and found no reports of blood clots.
The body is now recommending lifting the suspension on the Sisonke study but says there should be better screening and monitoring of participants at high risk of blood clotting disorders.
The regulator also says all participants should be informed about the risk of developing the disorder.
South Africa suspended the trial after US Federal Health Agencies recommended the pause.
Six women there developed a blood clotting disorder after receiving the Johnson & Johnson vaccine.
More Stories
Zuma Rescission Application Denied
State Capture Commission Seeks Another Extension
IEC Ready For Voter Registration Weekend
NICD Reports 4 215 New COVID-19 Cases In SA
ANC Slams Carl Niehaus
Another Soldier Arrested For Cross-Border Vehicle Smuggling
Deputy Minister Hlengiwe Mkhize Dies At 69
SA Reports 4 667 New COVID-19 Cases
Matric Exams to start on 27 October
HSF Wants Court To Set Aside Fraser Decision On Zuma Parole
Judge Hlophe Heads To Court
SA Reports 3 699 New COVID-19 Cases